fexaramine,
Fexaramine,
574013-66-4,
CHEMBL192966,
CHEBI:80003,
(E)-methyl 3-(3-(N-((4'-(dimethylamino)-[1,1'-biphenyl]-4-yl)methyl)cyclohexanecarboxamido)phenyl)acrylate,
FEX,
C32H36N2O3,
AC1NS0YI,
A1-01872,
GTPL2744,
Fexaramine, >=98% (HPLC),
SCHEMBL17083218,
AOB5017,
HMS3677H09,
BCP15784,
EX-A2246,
3671AH,
BDBM50167161,
MFCD09971007,
ZINC13831232,
AKOS024457169,
CS-3884,
DB02545,
NCGC00167776-01,
AK175872,
AS-35318,
BC600742,
HY-10912,
RT-012704,
B7108,
C15649,
BRD-K34170797-001-01-1,
(E)-3-{3-[Cyclohexanecarbonyl-(4''-dimethylamino-biphenyl-4-ylmethyl)-amino]-phenyl}-acrylic acid methyl ester,
2-Propenoic acid, 3-(3-((cyclohexylcarbonyl)((4'-(dimethylamino)(1,1'-biphenyl)-4-yl)methyl)amino]phenyl)-, methyl ester,
2-Propenoic acid,3-[3-[(cyclohexylcarbonyl)[[4'-(dimethylamino)[1,1'-biphenyl]-4-yl]methyl]amino]phenyl]-,methyl ester,
3-[[4'-(Dimethylamino)-4-biphenylylmethyl](cyclohexylcarbonyl)amino]cinnamic acid methyl ester,
3-[3-[(Cyclohexylcarbonyl)-[[4'-(dimethylamino)-[1,1'-biphenyl]-4-yl]methyl]amino]phenyl]-2-propenoic acid methyl ester,
3-[3-[(cyclohexylcarbonyl)-[[4'-(dimethylamino)-[1,1'-biphenyl]-4-yl]methyl]amino]phenyl]-2-propenoicacidmethylester,
methyl (E)-3-[3-[cyclohexanecarbonyl-[[4-(4-dimethylaminophenyl)phenyl]methyl]amino]phenyl]prop-2-enoate,
methyl (Z)-3-[3-[cyclohexanecarbonyl-[[4-(4-dimethylaminophenyl)phenyl]methyl]amino]phenyl]prop-2-enoate,
D01MYO,
C32-H36-N2-O3,
CID5326713,
C474615,
2-Propenoic acid, 3-[3-[(cyclohexylcarbonyl)[[4'-(dimethylamino)[1,1'-biphenyl]-4-yl]methyl]amino]phenyl]-, methyl ester,
3-[3-[(Cyclohexylcarbonyl)-[[4'-(dimethylamino)-[1,1'-biphenyl]-4-yl]methyl]amino]phenyl]-2-propenoicacid methylester,
Methyl 3-{3-[(Cyclohexylcarbonyl){[4'-(Dimethylamino)biphenyl-4-Yl]methyl}amino]phenyl}acrylate,